Total Visits
| Views | |
|---|---|
| Long-Term ... | 175 |
Total Visits Per Month
| June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | |
|---|---|---|---|---|---|---|---|
| Long-Term ... | 1 | 60 | 12 | 3 | 7 | 9 | 3 |
File Visits
| Views | |
|---|---|
| long_term_efficacy_safety_long_acting_complement_c5_inhibitor_ravulizumab_treatment_atypical_hemolytic_uremic_syndrome_adults_2021.pdf | 46 |
| long_term_efficacy_safety_long_acting_complement_c5_inhibitor_ravulizumab_treatment_atypical_hemolytic_uremic_syndrome_adults_2021_material_suplementari.pdf | 27 |
Top country views
| Views | |
|---|---|
| United States | 112 |
| Singapore | 17 |
| China | 11 |
| Germany | 7 |
| Spain | 5 |
| Australia | 4 |
| Japan | 4 |
| Brazil | 3 |
| Sweden | 3 |
| Hong Kong | 2 |
Top cities views
| Views | |
|---|---|
| Seattle | 61 |
| Singapore | 16 |
| Ashburn | 11 |
| Chandler | 11 |
| Beijing | 9 |
| Barcelona | 4 |
| Frankfurt am Main | 4 |
| Tokyo | 4 |
| Sydney | 3 |
| Almont | 2 |



